State-of-the-Art Paper
The Sympathetic Nervous System in Heart Failure: Physiology, Pathophysiology, and Clinical Implications

https://doi.org/10.1016/j.jacc.2009.05.015Get rights and content
Under an Elsevier user license
open archive

Heart failure is a syndrome characterized initially by left ventricular dysfunction that triggers countermeasures aimed to restore cardiac output. These responses are compensatory at first but eventually become part of the disease process itself leading to further worsening cardiac function. Among these responses is the activation of the sympathetic nervous system (SNS) that provides inotropic support to the failing heart increasing stroke volume, and peripheral vasoconstriction to maintain mean arterial perfusion pressure, but eventually accelerates disease progression affecting survival. Activation of SNS has been attributed to withdrawal of normal restraining influences and enhancement of excitatory inputs including changes in: 1) peripheral baroreceptor and chemoreceptor reflexes; 2) chemical mediators that control sympathetic outflow; and 3) central integratory sites. The interface between the sympathetic fibers and the cardiovascular system is formed by the adrenergic receptors (ARs). Dysregulation of cardiac beta1-AR signaling and transduction are key features of heart failure progression. In contrast, cardiac beta2-ARs and alpha1-ARs may function in a compensatory fashion to maintain cardiac inotropy. Adrenergic receptor polymorphisms may have an impact on the adaptive mechanisms, susceptibilities, and pharmacological responses of SNS. The beta-AR blockers and the inhibitors of the renin-angiotensin-aldosterone axis form the mainstay of current medical management of chronic heart failure. Conversely, central sympatholytics have proved harmful, whereas sympathomimetic inotropes are still used in selected patients with hemodynamic instability. This review summarizes the changes in SNS in heart failure and examines how modulation of SNS activity may affect morbidity and mortality from this syndrome.

Key Words

heart failure
sympathetic nervous system
adrenergic receptor
beta-blockers
sympatholytics
sympathomimetic inotropes

Abbreviations and Acronyms

AR
adrenergic receptor
ATP
adenosine triphosphate
cAMP
3′,5′-cyclic monophosphate
EPI
epinephrine
MIBG
metaiodobenzylguanidine
NE
norepinephrine
SNS
sympathetic nervous system

Cited by (0)